Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults

计划入组 25 人 · 首次发布于 2017 年 2 月 8 日

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

计划入组 38 人 · 首次发布于 2016 年 6 月 2 日

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

计划入组 124 人 · 首次发布于 2024 年 2 月 8 日

VF-1634

NTM-1634

SAB-953

SAB Biotherapeutics

United States

Terra Biological LLC

United States

STB INN AB

Sweden

Moderna Advances mRNA Hantavirus Vaccine Development as Deadly Cruise Ship Outbreak Highlights Urgent Medical Need

SAB Biotherapeutics' SAB-142 Shows Promising Safety Profile in Type 1 Diabetes Trial

SAB Biotherapeutics Completes Phase 1 Enrollment of SAB-142 for Type 1 Diabetes